Swelling, oedema, chronic oedema, lymphoedema, lipoedema, lipedema, lipo-lymphoedema. Seven words that look like synonyms and are often used as if they were. Search for any one of them and you will find pages that treat it as the umbrella, pages that treat it as a narrow diagnosis, and pages that quietly swap it for another. The confusion is understandable. Research papers, NHS pages, professional bodies and people describing their own lives use these words for different jobs. This article explains how the terms are used in the sources, where their meanings overlap, and what each source set was designed to study.
Editorial note: this article is educational and has not been medically reviewed. It explains vocabulary and source scope. It is not a guide to working out what any individual has, and it offers no checklist, signs to look for or self-assessment.
Start with the broadest words
Swelling is an everyday word for increased size, fullness or tightness that a person notices or another person observes. It reports an experience or a visible change and does not name a cause.
Oedema is the clinical description commonly used for excess fluid in tissue, though context and underlying mechanism still matter. Chronic oedema signals that swelling is persistent or recurrent over time. It is a wider service and research term than lymphoedema, because chronic swelling can arise through more than one pathway. The first chapter of the Field Guide treats these words as starting points for questions, not conclusions.
Moffatt and colleagues (Lymphatic Research and Biology, 2019) used the chronic oedema frame to study UK community nursing services. The study shows that broad swelling language can represent substantial care needs and service demand. It describes a service caseload, so it cannot give whole-population prevalence, and it does not show that each person represented had the same mechanism.
Lymphoedema: a lymphatic context
Lymphoedema is used for swelling associated with impaired lymphatic transport or lymphatic system dysfunction. The 2020 International Society of Lymphology consensus places the term within a clinical framework that considers lymphatic anatomy, transport, tissue change, history and assessment. The NHS lymphoedema page gives a shorter public explanation and signposting.
These two agree on the broad idea and differ in purpose. The consensus is a scholarly synthesis. The NHS page is written for public orientation. Shared wording between them does not amount to a personal examination.
Within lymphoedema writing, primary and secondary are context labels. Primary generally refers to lymphatic development or function described as intrinsic to the lymphatic system. Secondary refers to lymphatic dysfunction discussed alongside another event, condition or intervention. A separate article on this site goes into how those labels work in research.
Lipoedema and lipedema: one condition description, two spellings
UK sources and this site use lipoedema. Much international literature uses lipedema, including the title of the 2024 S2k guideline (Faerber and colleagues, Journal der Deutschen Dermatologischen Gesellschaft). They are search variants, not two diagnoses. Likewise, lymphedema and lymphoedema are the same word in American and British spelling.
The practical consequence is for searching. A query limited to one spelling can miss relevant papers written with the other. Anyone comparing UK guidance with international research needs to keep both forms in view.
Lipoedema is used as a clinical description involving adipose distribution and symptoms that may include pain, tenderness, heaviness or easy bruising. The S2k guideline reached its description through a systematic search and structured consensus, and the NHS lipoedema page gives a UK public overview. Criteria and terminology vary across research, services and historical teaching, and the guideline notes the absence of a laboratory biomarker. A recognisable description in a source is a different thing from a validated test.
Lipo-lymphoedema: naming an overlap
Lipo-lymphoedema is used in some clinical and educational settings for a person described as having features discussed under lipoedema together with lymphatic oedema or lymphatic dysfunction. The combined term acknowledges overlap rather than forcing every experience into one category. It does not establish which feature came first, whether one caused the other, or whether one inevitably becomes the other. A progression story needs longitudinal evidence with consistent definitions, and the sources used here do not provide it.
Venous oedema: a neighbouring term
Venous oedema is discussed in relation to venous function. Source writing keeps it apart from lymphoedema, lipoedema and lipo-lymphoedema, and it should not be relabelled silently as one of them. Its relevance here is as a reminder that swelling has several possible explanations, and that explanation is established through clinical assessment, not through vocabulary.
Where the meanings overlap, and where the study scopes do not
Overlap in language is not the same as overlap in populations. A useful way to read is to ask which question each source set was built to answer.
- Chronic oedema studies such as the UK community nursing work describe a service caseload and the burden of long-term swelling. They are broad by design.
- Lymphoedema consensus and trials concern people described within a lymphatic framework, often with a defined history. Many of the trials and reviews cited in the Field Guide, such as DiSipio and colleagues (Lancet Oncology, 2013), concern arm lymphoedema after breast cancer treatment.
- Lipoedema guidelines and reviews, such as the S2k guideline, the 2024 imaging systematic review (van la Parra and colleagues) and the 2025 quality-of-life meta-analysis (Günay and colleagues), concern populations described as having lipoedema and use varying criteria.
- Procedure guidance from NICE is narrower again. HTG618 (formerly IPG721) addresses liposuction for chronic lipoedema, and HTG622 (formerly IPG723) addresses liposuction for chronic lymphoedema. The two conditions and evidence contexts are not interchangeable, and neither document is a general care pathway.
Putting those side by side explains many puzzling moments in reading. A finding about "chronic oedema" in a nursing caseload and a finding about lymphoedema after a specific cancer treatment can both be true and still describe different people. A lipoedema review and a lymphoedema consensus can each be internally coherent while saying little about each other's populations.
How UK sources use the words
Each UK source type has its own purpose.
- NHS pages orient the public and signpost. They are not research cohorts or validation studies.
- NICE documents cover named scopes. NG101 is specific to early and locally advanced breast cancer. NG141 concerns cellulitis and erysipelas antimicrobial prescribing, so its use here is infection and service context only. The two procedure documents above are research and governance positions on named procedures. Within the Field Guide's source set, there is no single comprehensive NICE pathway for general lymphoedema, chronic oedema or lipoedema.
- The British Lymphology Society provides professional and operational context.
- The Lymphoedema Support Network provides patient information and signposting.
None of these is automatically peer-reviewed efficacy evidence, and none decides what a person has. The UK services context page compares what each can and cannot do.
Why a description is not a diagnosis
Several different things get called by the same word, and the Field Guide separates them. A clinical description names a pattern or experience. A consensus document records an expert synthesis. Guidance turns evidence and professional judgement into advice for a defined audience. Validation asks whether a measure performs for a stated purpose and population. Diagnosis is a qualified clinical conclusion reached through assessment. A source may be strong in one role and unsuitable for another. Body size and shape also do not settle any of these terms. Weight change, age, hormones, mobility, medication and illness can all affect appearance without proving a particular condition, and the sources do not treat weight as a test.
Practical reading habits
- Note which spelling and term a source uses, and search the variants.
- Ask whether the term names an experience, a mechanism, a service category or a study population.
- Check what the scope of the source is: public orientation, named guideline, consensus, trial or qualitative study.
- Treat a combined term, such as lipo-lymphoedema, as a description of overlap and not as a timeline.
- Keep your own words. A short note of what changed, where, when and how it affects daily life travels well into a professional conversation. The local-only sheets on the resources page follow that approach without scores or uploads.
Changing or urgent concerns
A new, rapidly changing or worrying swelling or skin concern needs appropriate NHS or urgent-care advice and cannot be worked out from a glossary. Fever or feeling unwell with a skin change, breathing difficulty, chest pain or collapse needs emergency help.
The takeaway
These words overlap in everyday and professional use because they describe adjacent territory. They separate when you ask what each source studied, what it was written for, and what it leaves open. For definitions with their limits attached, use the glossary, and for the longer treatment, the Field Guide.
Sources
- International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2020 Consensus Document. Lymphology. 2020;53(1):3-19. DOI 10.2458/lymph.4649.
- Moffatt CJ et al. Prevalence and risk factors for chronic edema in U.K. community nursing services. Lymphatic Research and Biology. 2019;17(2):147-154. DOI 10.1089/lrb.2018.0086.
- Faerber G et al. S2k guideline lipedema. J Dtsch Dermatol Ges. 2024;22(9):1303-1315. DOI 10.1111/ddg.15513.
- DiSipio T et al. Incidence of unilateral arm lymphoedema after breast cancer. Lancet Oncology. 2013;14(6):500-515. PMID 23540561.
- van la Parra RFD et al. Diagnostic imaging in lipedema: a systematic review. Obesity Reviews. 2024;25(1):e13648. DOI 10.1111/obr.13648.
- Günay UB, Talak GR, Demiröz A. Health-related quality of life among lipedema patients. Phlebology. 2025. PMID 41436421.
- NHS. Lymphoedema and Lipoedema.
- NICE. HTG618, HTG622, NG101 and NG141.
- British Lymphology Society, thebls.com. Lymphoedema Support Network, lymphoedema.org.
